Rogerson SJ, Unger HW. Pregnancy and malaria: the perfect storm. Curr Opin Infect Dis. 2022;35:410–6.
The WOMAN-2 trial collaborators. Maternal anaemia and the risk of postpartum haemorrhage: a cohort analysis of data from the WOMAN-2 trial. Lancet Glob Health. 2023;11:e1249–59.
Unger HW, Acharya S, Arnold L, Wu C, van Eijk AM, Gore-Langton GR, et al. The impact and control of malaria in pregnancy and lactating women in the Asia-Pacific region – a systematic review. Lancet Glob Health. 2023;11:e1805–18.
Rogerson SJ, Desai M, Mayor A, Sicuri E, Taylor SM, van Eijk AM. Burden, pathology, and costs of malaria in pregnancy: new developments for an old problem. Lancet Infect Dis. 2018;18:e107–18.
Kakuru A, Staedke SG, Dorsey G, Rogerson S, Chandramohan D. Impact of Plasmodium falciparum malaria and intermittent preventive treatment of malaria in pregnancy on the risk of malaria in infants: a systematic review. Malar J. 2019;18:304.
Moore KA, Simpson JA, Scoullar MJL, McGready R, Fowkes FJI. Quantification of the association between malaria in pregnancy and stillbirth: a systematic review and meta-analysis. Lancet Glob Health. 2017;5:e1101–12.
WHO. Guidelines for malaria (25 November 2022). Geneva: World Health Organization; 2022.
Unger HW, Rosanas-Urgell A, Robinson LJ, Ome-Kaius M, Jally S, Umbers AJ, et al. Microscopic and submicroscopic Plasmodium falciparum infection, maternal anaemia and adverse pregnancy outcomes in Papua New Guinea: a cohort study. Malar J. 2019;18:302.
van Eijk AM, Stepniewska K, Hill J, Taylor SM, Rogerson SJ, Cottrell G, et al. Prevalence of and risk factors for microscopic and submicroscopic malaria infections in pregnancy: a systematic review and meta-analysis. Lancet Glob Health. 2023;11:e1061–74.
Chico RM, Chaponda EB, Ariti C, Chandramohan D. Sulfadoxine-pyrimethamine exhibits dose-response protection against adverse birth outcomes related to malaria and sexually transmitted and reproductive tract infections. Clin Infect Dis. 2017;64:1043–51.
Roh ME, Kuile FOT, Rerolle F, Glymour MM, Shiboski S, Gosling R, et al. Overall, anti-malarial, and non-malarial effect of intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine on birthweight: a mediation analysis. Lancet Glob Health. 2020;8:e942–53.
Cates JE, Westreich D, Unger HW, Bauserman A, Adair L, Cole SR, et al. Intermittent preventive therapy in pregnancy and incidence of low birth weight in malaria-endemic countries. Am J Public Health. 2018;108:399–406.
Unger HW, Wangnapi RA, Ome-Kaius M, Boeuf P, Karl S, Mueller I, et al. Azithromycin-containing intermittent preventive treatment in pregnancy affects gestational weight gain, an important predictor of birthweight in Papua New Guinea – an exploratory analysis. Matern Child Nutr. 2016;12:699–712.
Unger HW, Ome-Kaius M, Wangnapi RA, Umbers AJ, Hanieh S, Suen CS, et al. Sulphadoxine-pyrimethamine plus azithromycin for the prevention of low birthweight in Papua New Guinea: a randomised controlled trial. BMC Med. 2015;13:9.
Kim S, Naziripour A, Prabhala P, Horvath V, Junaid A, Breault D, et al. Direct therapeutic effect of sulfadoxine-pyrimethamine on nutritional deficiency-induced enteric dysfunction in a human Intestine Chip. EBioMedicine. 2023;99:104921.
Waltmann A, McQuade ETR, Chinkhumba J, Operario DJ, Mzembe E, Itoh M, et al. The positive effect of malaria IPTp-SP on birthweight is mediated by gestational weight gain but modifiable by maternal carriage of enteric pathogens. EBioMedicine. 2022;77:103871.
Robbers G, Vogel JP, Mola G, Bolgna J, Homer CSE. Maternal and newborn health indicators in Papua New Guinea – 2008–2018. Sex Reprod Health Matters. 2019;27:1686199.
NDOH. National Malaria Strategic Plan 2014–2018. Port Moresby, Papua New Guinea: Papua New Guinea National Department of Health (NDOH), 2014.
Muller I, Bockarie M, Alpers M, Smitth T. The epidemiology of malaria in Papua New Guinea. Trends Parasitol. 2003;19:253–9.
Seidahmed O, Kurumop S, Jamea S, Tandrapah A, Timbi D, Hetzel M, et al. Papua New Guinea Malaria Indicator Survey 2019–2020: Final report on malaria prevention, infection prevalence, and treatment-seeking. Papua New Guinea Institute of Medical Research. Goroka, Papua New Guinea: 2021.
Kayentao K, Garner P, van Eijk AM, Naidoo I, Roper C, Mulokozi A, et al. Intermittent preventive therapy for malaria during pregnancy using 2 vs 3 or more doses of sulfadoxine-pyrimethamine and risk of low birth weight in Africa: systematic review and meta-analysis. JAMA. 2013;309(6):594–604.
Madanitsa M, Barsosio HC, Minja DTR, Mtove G, Kavishe RA, Dodd J, et al. Effect of monthly intermittent preventive treatment with dihydroartemisinin-piperaquine with and without azithromycin versus monthly sulfadoxine-pyrimethamine on adverse pregnancy outcomes in Africa: a double-blind randomised, partly placebo-controlled trial. Lancet. 2023;401:1020–36.
Cleary E, Hetzel MW, Clements ACA. A review of malaria epidemiology and control in Papua New Guinea 1900 to 2021: progress made and future directions. Front Epidemiol. 2022;2:980795.
Riddell MA, Vallely LM, Mengi A, Badman SG, Low N, Wand H, et al. Point-of-care testing and treatment of sexually transmitted and genital infections to improve birth outcomes in high-burden, low-resource settings (WANTAIM): a pragmatic cluster randomised crossover trial in Papua New Guinea. Lancet Glob Health. 2024;12:e641–51.
Wangnapi RA, Soso S, Unger HW, Sawera C, Ome M, Umbers AJ, et al. Prevalence and risk factors for Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis infection in pregnant women in Papua New Guinea. Sex Transm Infect. 2015;91:194–200.
Zhou H, Wang A, Huang X, Guo S, Yang Y, Martin K, Tian X, et al. Quality antenatal care protects against low birth weight in 42 poor counties of Western China. PLoS ONE. 2019;14:e0210393.
Weyori AE, Seidu AA, Aboagye RG, Holmes FA, Okyere J, Ahinkorah BO. Antenatal care attendance and low birth weight of institutional births in sub-Saharan Africa. BMC Pregnancy Childbirth. 2022;22:283.
Dosoo DK, Malm K, Oppong FB, Gyasi R, Oduro A, Williams J, et al. Effectiveness of intermittent preventive treatment in pregnancy with sulphadoxine-pyrimethamine (IPTp-SP) in Ghana. BMJ Glob Health. 2021;6:e005877.
Mace KE, Chalwe V, Katalenich BL, Nambozi M, Mubikayi L, Mulele CK, et al. Evaluation of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a retrospective birth outcomes study in Mansa, Zambia. Malar J. 2015;14:69.
Karl S, Suen CSLW, Unger HW, Ome-Kaius M, Mola G, White L, et al. Preterm or not – an evaluation of estimates of gestational age in a cohort of women from rural Papua New Guinea. PLoS One. 2015;10:e0124286.